Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Anebulo Pharmaceuticals Inc. Common Stock
ANEB | US
0.40
USD-0.07
-14.74%
ANEB | US
About Anebulo Pharmaceuticals Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
0.40
Open
0.40
High
0.40
Low
0.40
Anebulo Pharmaceuticals Inc. a clinical-stage biotechnology company engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. Its lead product candidate is ANEB-001 a small molecule cannabinoid receptor antagonist which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. The company was incorporated in 2020 and is based in Lakeway Texas.
View LessANEB | US
Risk
117.9
Sharpe
-0.45
Luna's Score
30/100
Recommendation
Sell
Luna says (ANEB | US)
What's Working
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
117.8%1 month
117.9%3 months
179.8%6 months
161.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
12.45
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-6.54
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
10.39M
MarketCap(USD)
10.39M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-113.80
Short ratio
0.94
Short perc.
0.37
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.10
Range1M
0.15
Range3M
0.82
Volumes: Market Activity
Rel. volume
1.47
Price X volume
2.18K
